141 related articles for article (PubMed ID: 23471064)
1. Life sciences venture capital in emerging markets.
Chakma J; Sammut SM; Agrawal A
Nat Biotechnol; 2013 Mar; 31(3):195-201. PubMed ID: 23471064
[No Abstract] [Full Text] [Related]
2. How Indian biotech is driving innovation.
Nogrady B
Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
[No Abstract] [Full Text] [Related]
3. Corporate venture capital and Cambridge.
McCammon MG; Pio E; Barakat S; Vyakarnam S
Nat Biotechnol; 2014 Oct; 32(10):975-8. PubMed ID: 25299912
[No Abstract] [Full Text] [Related]
4. Biotech boot camp.
Ledford H
Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
[No Abstract] [Full Text] [Related]
5. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
6. Showcasing bioscience in Rhode Island.
Spero D
R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
[TBL] [Abstract][Full Text] [Related]
7. Research not fit to print.
Nat Biotechnol; 2016 Feb; 34(2):115. PubMed ID: 26849496
[No Abstract] [Full Text] [Related]
8. The service-based bioeconomy.
Nat Biotechnol; 2014 Jul; 32(7):597. PubMed ID: 25004205
[No Abstract] [Full Text] [Related]
9. The case for entrepreneurship in R&D in the pharmaceutical industry.
Douglas FL; Narayanan VK; Mitchell L; Litan RE
Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
[TBL] [Abstract][Full Text] [Related]
10. Big pharma wants you.
Mack GS
Nat Biotechnol; 2006 Nov; 24(11):1317-9. PubMed ID: 17162751
[TBL] [Abstract][Full Text] [Related]
11. Fates intertwined.
Cooper GJ
Nat Biotechnol; 2006 Mar; 24(3):252-4. PubMed ID: 16525372
[No Abstract] [Full Text] [Related]
12. When times get tough.
Jong S
Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
[No Abstract] [Full Text] [Related]
13. The three pillars of bioentrepreneurship.
Schoemaker HJ; Schoemaker AF
Nat Biotechnol; 1998 May; 16 Suppl():13-5. PubMed ID: 9591253
[No Abstract] [Full Text] [Related]
14. A venture capital view of challenges, opportunities, and innovation in biomedical research.
Ratcliffe LT
Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
[TBL] [Abstract][Full Text] [Related]
15. Indian biotechnology--rapidly evolving and industry led.
Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
[No Abstract] [Full Text] [Related]
16. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
Miletich JP
Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
[No Abstract] [Full Text] [Related]
17. Bioentrepreneurship 2002: at home in your lab.
Eisenhardt PE
Anal Bioanal Chem; 2002 Jan; 372(1):9-11. PubMed ID: 11939216
[No Abstract] [Full Text] [Related]
18. Dissecting monoclonal antibody mega-deals.
Villiger R; Bogdan B
MAbs; 2009; 1(2):172-8. PubMed ID: 20061828
[TBL] [Abstract][Full Text] [Related]
19. Conclusions: promoting biotechnology innovation in developing countries.
Thorsteinsdóttir H; Quach U; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl(Suppl 12):DC48-52. PubMed ID: 15583685
[No Abstract] [Full Text] [Related]
20. South Korean biotechnology--a rising industrial and scientific powerhouse.
Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
